Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Persimmon Sees Rise In Half Year Earnings

Tue, 21st Aug 2018 07:38

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday with US-China trade talks in focus, as Persimmon reported an increased profit for the first half. IG futures indicate the FTSE 100 index is to open down 18.36 points at 7,572.90. The blue chip index closed up 0.4% at 7,591.26 on Monday. In early UK corporate news, miner BHP Billiton paid out to shareholders above its policy level, with annual profit rising though short of consensus.For the 12 months to June, BHP is paying a "record" final dividend of 63 US cents a share, 17 cents above its policy of paying 50% of underlying attributable profit.The total dividend for BHP's financial year was 118 cents, far higher than the 83 cents paid out a year earlier and above analyst consensus of a 116 cents return.BHP's pretax profit rose to USD14.75 billion from USD11.14 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation was up 20% to USD23.18 billion.Housebuilder Persimmon said it saw a strong first half of 2018 reflecting its commitment to delivery of high quality growth.For the half year to the end of June, revenue rose 5% to GBP1.84 billion from GBP1.75 billion last year and pretax profit was up 13% to GBP516.3 million from GBP457.4 million last year. New home sales increased 4% to 8,072 from 7,794 last year - with an additional 278 new homes delivered in the period.Persimmon said it returned surplus capital to shareholders of 125 pence per share in March 2018, in addition to the payment of 110 pence per share paid in July. The company added that it remained committed to return surplus capital of at least 235 pence per share for the next two years ending 2020, and 110 pence per share in 2021."The group has a robust platform to continue to deliver successful outcomes based on its high quality land bank, strong forward sales, excellent financial position, and experienced management team. We believe we are well positioned to deliver further high quality, sustainable growth," said Chief Executive Jeff Fairburn.Anglo-Swedish drugmaker AstraZeneca said its non-small-cell lung carcinoma drug Tagrisso has been approved in Japan as a first line treatment. "Tagrisso is already approved in Japan for the treatment of patients with EGFR T790M mutation-positive inoperable or recurrent NSCLC that is resistant to existing 1st-line EGFR-inhibitor medicines. Today's approval moves the use of Tagrisso to the 1st-line setting, replacing older medicines which, given the high prevalence of the EGFR mutation in Japan, offers an important new treatment option for these patients," said Dave Fredrickson, head of its Oncology unit. Gold miner Polymetal International reported strong earnings on the back of solid operational delivery in the first half of the year.For the half year to the end of June, revenue was up 16% to USD789.0 million from USD683.0 million last year and net earnings were up 46% to USD175.0 million from USD120.0 million the year before. Gold sales in the first half were up 17% at 445,000 ounces, although silver was down 2% at 12.1 million ounces.Polymetal declared an interim dividend of 0.17 cents, up 21% from 0.14 cents paid last year. "We expect stronger production and free cash flow generation for the second half and remain focused on steadily progressing our further growth pipeline, including full ramp-up of Kyzyl, while generating meaningful dividends to our shareholders," said Chief Executive Vitaly Nesis.The Japanese Nikkei 225 index closed up 0.1%. In China, the Shanghai Composite is up 1.4%, while the Hang Seng index in Hong Kong is up 0.6%.Asian stock markets are higher following the modest gains overnight on Wall Street amid optimism over US-China trade talks. The dollar declined after a report from Reuters said that US President Donald Trump accused China, as well as Europe, of manipulating their currencies and also said he was "not thrilled" with Federal Reserve Chair Jerome Powell for raising interest rates.In the US on Monday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.4%, S&P 500 up 0.2% and Nasdaq Composite up 0.1%. The pound was up against the dollar quoted at USD1.2843 compared to USD1.2761 on Monday.Still to come in the economic calendar in Europe is UK public sector borrowing figures at 0930 BST.
More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.